Synthetic Superdisintegrants segment is expected to drive the growth of the global Superdisintegrants market by type
According to a new market research study of ‘‘Superdisintegrants Market to 2027 - Global Analysis and Forecasts by Type, Formulation, Therapeutic Area’ the global Superdisintegrants market is projected to reach US$ 659.17 Mn in 2027 from US$ 369.56 Mn in 2019. The market is projected to grow with a CAGR of 7.6% from 2020-2027. The report provides trends predominating in the global superdisintegrants market and the factors driving the market and also the factors that act as hindrances.
The world is witnessing exponential growth in the prevalence of chronic diseases. Factors such as progression of viruses, bacteria, parasites, coupled with growing adoption of sedentary lifestyle, genetic conditions, and consumption of poor diet are responsible for the growing prevalence of these diseases. This exponential increase in the prevalence of diseases is leading to the adoption of solid dosage forms for disease treatment. For instance, according to data published by the World Health Organization (WHO) in 2019, an estimated 71.0 million people suffer from hepatitis C virus infection across the world. Oral drug delivery remains the most common route of drug administration in the healthcare world. Solid dosage forms typically include tablets, capsules, and powders for the treatment of particular disease condition. Moreover, growing emphasis on novel drug delivery approach is expected to boost the awareness and focus on the utilization of orally disintegrating tablets during the forecast period. Superdisintegrants or orally disintegrating tablets are gaining traction due to advantages such as ease of drug administration and better compliance for pediatric and geriatric patients. Furthermore, superdisintegrant tablets offer several benefits over traditional capsules and tablets. Advantages of disintegrants include the ability for accurate dosing, fast action, superior patient compliance, better palatability, and cost effectiveness, as well as ease of administration, no risk of airway suffocation during swallowing, and flexibility in terms of large and small molecules. Such salient features of superdisintegrant tablets represent massive potential for its adoption during tablet formulations. Therefore, owing to the factors mentioned above, the market is likely to propel during the forecast period.
In 2019, the Synthetic Superdisintegrants segment accounted for the largest market share in the global Superdisintegrants market by type. Synthetic disintegrants are more effective in lower concentrations as compared to starch; also they incorporate superior intragranularity, such merits of synthetic superdisintegrants are projected to drive the synthetic superdisintegrants segment in the global superdisintegrants market during the forecast period.
The Superdisintegrants market majorly consists of players such as Ashland, BASF SE, DowDupont Inc., JRS PHARMA, COREL PHARMA CHEM, Roquette Frères, Asahi Kasei Corporation, Merck KGaA, Avantor, Inc., and DFE Pharma. among others. Several companies are concentrating on organic strategies, such as product launch and product approvals. For instance, in April 2018, the partnership of Perrigo Company Plc and Dexcel Pharma Technologies Ltd. launched Omeprazole ODT—orally disintegrating tablets to treat heartburn. The company took strategic step to expand geriatric customer base.
The report segments global Superdisintegrants market as follows:
Global Superdisintegrants Market - By Type
Global Superdisintegrants Market - By Formulation
Global Superdisintegrants Market - By Therapeutic Area
Global Superdisintegrants Market - By Geography
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@reportsweb.com